Showing results (261-270 of 369) with videos related to

Sort By:
Pageof 37
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 8, 2025
Safety and Efficacy of Adoptive Transfer of Stem Cell Memory Enriched Virus Specific T Cells against CMV and EBVXun-Hong Cao, Xu-Ying Pei, Yuan-Yuan Zhang, et al.
European Journal of Haematology|January 28, 2017
Viral encephalitis after haplo-identical hematopoietic stem cell transplantation: Causative viral spectrum, characteristics, and risk factorsXiao-Hui Zhang, Jia-Min Zhang, Wei Han, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 16, 2024
Susceptibility of Mitophagy-Deficient Tumors to Ferroptosis Induction by Relieving the Suppression of Lipid PeroxidationShan Liu, Jing-Hong Chen, Li-Chao Li, et al.
Zhonghua Nei Ke Za Zhi|January 19, 2013
[The efficacy and safety of rituximab in treatment of Epstein-Barr virus disease post allogeneic hematopoietic stem-cell transplantation]Lan-ping Xu, Dai-hong Liu, Kai-yan Liu, et al.
Cancer Communications (London, England)|October 24, 2022
Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long-term clinical outcomes and health-related quality of life assessmentChen-Hua Yan, Yu Wang, Yu-Qian Sun, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2014
Extramedullary relapse of acute leukemia after haploidentical hematopoietic stem cell transplantation: incidence, risk factors, treatment, and clinical outcomesXiao-Dong Mo, Jun Kong, Ting Zhao, et al.
Blood|December 29, 2005
Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantationDao-Pei Lu, Lujia Dong, Tong Wu, et al.
Blood Cell Therapy|June 9, 2025
PD-1 inhibitor in patients with minimal residual disease who failed donor lymphocyte infusion or interferon after allogeneic haematopoietic stem cell transplantationLing Ma, Si-Qi Li, Wei Han, et al.
Scientific Reports|February 13, 2020
Prevalence and risk factors of having antibodies to class I and II human leukocyte antigens in older haploidentical allograft candidatesLe-Qing Cao, Meng Lv, Lan-Ping Xu, et al.
Zhonghua Nei Ke Za Zhi|July 26, 2011
[The efficacy and safety of second allogeneic hematopoietic stem cell transplantation for post-transplant hematologic malignancies relapse]Yu-Hong Chen, Lan-Ping Xu, Huan Chen, et al.
Pageof 37